APLT insider transaction filings
Applied Therapeutics, Inc. — 46 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-02-04. Screen APLT transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for APLT between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Applied Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-04 | 4 | Kanter Stacy J. — Director | Disposition to issuer (D): 22,500 · Code (U): 42,500 · Disposition to issuer (D): 20,460 (derivative) · Disposition to issuer (D): 10,230 (derivative) · Disposition to issuer (D): 16,500 (derivative) · Disposition to issuer (D): 16,500 (derivative) · +1 more | EDGAR |
| 2026-02-03 | 4 | Chinoporos Constantine — See Remarks | Grant/award (A): 437,500 @ $0 · Disposition to issuer (D): 1,000,000 · Code (U): 57,111 | EDGAR |
| 2026-02-03 | 4 | Funtleyder Leslie D. — Chief Financial Officer, Director | Grant/award (A): 1,187,500 @ $0 · Disposition to issuer (D): 2,375,000 · Code (U): 152,959 · Disposition to issuer (D): 20,460 (derivative) · Disposition to issuer (D): 10,230 (derivative) · Disposition to issuer (D): 16,500 (derivative) · +3 more | EDGAR |
| 2026-02-03 | 4 | Bailey Evan Prescott — Chief Medical Officer | Grant/award (A): 437,500 @ $0 · Disposition to issuer (D): 1,235,915 · Code (U): 60,901 · Disposition to issuer (D): 19,531 (derivative) · Disposition to issuer (D): 4,883 (derivative) | EDGAR |
| 2026-02-03 | 4 | Lerner Teena — Director | Disposition to issuer (D): 22,500 · Code (U): 82,922 · Disposition to issuer (D): 20,460 (derivative) · Disposition to issuer (D): 10,230 (derivative) · Disposition to issuer (D): 16,500 (derivative) · Disposition to issuer (D): 16,500 (derivative) · +2 more | EDGAR |
| 2026-02-03 | 4 | Hooks Corwin Dale — Chief Commercial Officer | Grant/award (A): 312,500 @ $0 · Disposition to issuer (D): 862,500 · Code (U): 5,753 | EDGAR |
| 2026-02-03 | 4 | SKYLER JAY S — Director | Disposition to issuer (D): 22,500 · Code (U): 42,500 · Disposition to issuer (D): 20,460 (derivative) · Disposition to issuer (D): 10,230 (derivative) · Disposition to issuer (D): 16,500 (derivative) · Disposition to issuer (D): 16,500 (derivative) · +1 more | EDGAR |
| 2026-01-02 | 4 | Funtleyder Leslie D. — Chief Financial Officer, Director | Grant/award (A): 150,000 @ $0 | EDGAR |
| 2025-12-18 | 4 | Kanter Stacy J. — Director | Sale (S): 43,000 @ $0.11 | EDGAR |
| 2025-10-01 | 4 | Funtleyder Leslie D. — Chief Financial Officer, Director | Grant/award (A): 150,000 @ $0 | EDGAR |
| 2025-07-03 | 4 | Funtleyder Leslie D. — Chief Financial Officer, Director | Grant/award (A): 150,000 @ $0 · Grant/award (A): 150,000 @ $0 | EDGAR |
| 2025-06-17 | 4 | Bailey Evan Prescott — Chief Medical Officer | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-06-11 | 4 | Lerner Teena — Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Kanter Stacy J. — Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | SKYLER JAY S — Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | Chinoporos Constantine — See Remarks | Grant/award (A): 350,000 @ $0 | EDGAR |
| 2025-03-26 | 4 | Funtleyder Leslie D. — See Remarks, Director | Grant/award (A): 350,000 @ $0 | EDGAR |
| 2025-03-26 | 4 | Hooks Corwin Dale — Chief Commercial Officer | Grant/award (A): 250,000 @ $0 | EDGAR |
| 2025-03-06 | 4 | Perfetti Riccardo — Chief Medical Officer | Sale (S): 10,366 @ $0.44 | EDGAR |
| 2025-03-06 | 4 | Funtleyder Leslie D. — See Remarks, Director | Sale (S): 14,502 @ $0.44 | EDGAR |
| 2025-03-06 | 4 | Chinoporos Constantine — See Remarks | Sale (S): 447 @ $0.44 | EDGAR |
| 2025-02-07 | 4 | Funtleyder Leslie D. — See Remarks, Director | Sale (S): 22,950 @ $0.61 | EDGAR |
| 2025-02-07 | 4 | Perfetti Riccardo — Chief Medical Officer | Sale (S): 86,078 @ $0.61 | EDGAR |
| 2025-02-07 | 4 | Chinoporos Constantine — See Remarks | Sale (S): 28,117 @ $0.61 | EDGAR |
| 2024-12-20 | 4 | Funtleyder Leslie D. — See Remarks, Director | Grant/award (A): 150,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | JOHNSON JOHN — Executive Chairman, Director | Grant/award (A): 500,000 @ $0 · Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2024-08-23 | 4 | Funtleyder Leslie D. — Chief Financial Officer, Director | Sale (S): 13,530 @ $5.83 | EDGAR |
| 2024-08-23 | 4 | Perfetti Riccardo — Chief Medical Officer | Sale (S): 22,681 @ $5.83 | EDGAR |
| 2024-08-14 | 4 | Shendelman Shoshana — President and CEO, Director | Gift (G): 747,886 @ $0 · Gift (G): 747,886 @ $0 · Sale (S): 300,000 @ $5.98 · Sale (S): 357,423 @ $6.18 · Sale (S): 119,591 @ $5.93 | EDGAR |
| 2024-06-10 | 4 | Shendelman Shoshana — President and CEO, Director, 10% owner | Sale (S): 61,795 @ $4.32 | EDGAR |
| 2024-06-10 | 4 | Perfetti Riccardo — Chief Medical Officer | Sale (S): 22,003 @ $4.32 | EDGAR |
| 2024-06-10 | 4 | Funtleyder Leslie D. — Chief Financial Officer, Director | Sale (S): 16,980 @ $4.32 | EDGAR |
| 2024-06-07 | 4 | Kanter Stacy J. — Director | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2024-06-07 | 4 | Lerner Teena — Director | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2024-06-07 | 4 | SKYLER JAY S — Director | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2024-06-07 | 4 | MARCUS JOEL S — Director | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2024-06-06 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. — 10% owner Alexandria Venture Investments, LLC — 10% owner Alexandria Equities No. 7, LLC — 10% owner | Sale (S): 150,000 @ $4.21 · Sale (S): 150,000 @ $4.24 | EDGAR |
| 2024-04-15 | 4 | Hooks Corwin Dale — Chief Commercial Officer | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2024-03-18 | 4 | Shendelman Shoshana — President and CEO, Director, 10% owner | Sale (S): 318,573 @ $5.39 | EDGAR |
| 2024-03-18 | 4 | Perfetti Riccardo — Chief Medical Officer | Sale (S): 110,804 @ $5.39 | EDGAR |
| 2024-03-18 | 4 | Hansard Adam — Chief Commercial Officer | Sale (S): 48,871 @ $5.39 | EDGAR |
| 2024-03-18 | 4 | Funtleyder Leslie D. — Chief Financial Officer, Director | Sale (S): 28,727 @ $5.39 | EDGAR |
| 2024-03-18 | 4 | Chinoporos Constantine — See Remarks | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2023-12-22 | 4 | Shendelman Shoshana — President and CEO, Director, 10% owner | Grant/award (A): 1,100,000 @ $0 · Grant/award (A): 440,000 @ $0 | EDGAR |
| 2023-12-22 | 4 | Perfetti Riccardo — Chief Medical Officer | Grant/award (A): 450,000 @ $0 | EDGAR |
| 2023-12-22 | 4 | Hansard Adam — Chief Commercial Officer | Grant/award (A): 400,000 @ $0 | EDGAR |
Recent 8-K events — Applied Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-02-03 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-20 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-14 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events | EDGAR |
| 2025-06-17 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=APLT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →